0001140361-22-009657.txt : 20220315 0001140361-22-009657.hdr.sgml : 20220315 20220315213032 ACCESSION NUMBER: 0001140361-22-009657 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220311 FILED AS OF DATE: 20220315 DATE AS OF CHANGE: 20220315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Acheson David CENTRAL INDEX KEY: 0001836277 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35569 FILM NUMBER: 22743139 MAIL ADDRESS: STREET 1: C/O CHEMBIO DIAGNOSTICS, INC. STREET 2: 555 WIRELESS BOULEVARD CITY: HAUPPAUGE STATE: NY ZIP: 11788 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHEMBIO DIAGNOSTICS, INC. CENTRAL INDEX KEY: 0001092662 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880425691 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 555 WIRELESS BLVD. CITY: HAUPPAUGE STATE: NY ZIP: 11788 BUSINESS PHONE: (631) 924-1135 MAIL ADDRESS: STREET 1: 555 WIRELESS BLVD. CITY: HAUPPAUGE STATE: NY ZIP: 11788 FORMER COMPANY: FORMER CONFORMED NAME: Chembio Diagnostics Inc. DATE OF NAME CHANGE: 20040607 FORMER COMPANY: FORMER CONFORMED NAME: TRADING SOLUTIONS COM INC DATE OF NAME CHANGE: 19990805 4 1 form4.xml FORM 4 X0306 4 2022-03-11 0001092662 CHEMBIO DIAGNOSTICS, INC. CEMI 0001836277 Acheson David C/O CHEMBIO DIAGNOSTICS, INC. 555 WIRELESS BOULEVARD HAUPPAUGE NY 11788 true Restricted stock units 2022-03-11 4 A 0 32000 0 A Common stock 32000 32000 D Nonqualified stock options 1.25 2022-03-11 4 A 0 41143 0 A 2032-03-10 Common stock 41143 41143 D Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units are scheduled to vest in full immediately prior to the earlier of (i) the 2023 annual meeting of stockholders of the issuer and (ii) a Change in Control (as defined in the 2019 Omnibus Incentive Plan of the issuer). The nonqualified stock options are scheduled to vest and become exercisable in full immediately prior to the earlier to occur of (i) the 2023 annual meeting of stockholders of the issuer and (ii) a Change in Control. /s/ Mark L. Johnson, Attorney-in-Fact for David Acheson 2022-03-15